Insmed Reports First Quarter 2021 Financial Results and Provides Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Insmed (INSM) Misses Q1 EPS by 1c, Revenues Miss
May 6, 2021 8:19 AM EDTInsmed (NASDAQ: INSM) reported Q1 EPS of ($0.89), $0.01 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $40.21 million versus the consensus estimate of $41.64 million.
"Insmed is off to a strong start in 2021, with important advancements across each of our three... More
